A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 291,569 shares of PACB stock, worth $408,196. This represents 0.01% of its overall portfolio holdings.

Number of Shares
291,569
Holding current value
$408,196
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $1.03 Million - $2.8 Million
291,569 New
291,569 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $789,246 - $1.56 Million
139,197 New
139,197 $1.14 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $1.98 Million - $5.14 Million
493,119 New
493,119 $2.18 Million
Q1 2018

May 15, 2018

SELL
$2.05 - $3.23 $119,316 - $187,995
-58,203 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.59 - $5.44 $150,745 - $316,624
58,203
58,203 $154,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $315M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.